Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)

TWD 18.45

(-0.27%)

Market Cap (In TWD)

1.33 Billion

Revenue (In TWD)

396.14 Million

Net Income (In TWD)

-168.06 Million

Avg. Volume

209.62 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
16.7-22.7
PE
-
EPS
-
Beta Value
0.201
ISIN
TW0004195003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Kevin Chiang
Employee Count
-
Website
https://www.genomics.com.tw
Ipo Date
2013-12-16
Details
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services. The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan.